Robert Millham
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Biosimilars and Bioanalytical Methods
- Immune Cell Function and Interaction
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Colorectal Cancer Treatments and Studies
Papers in ⓘ
- Oncology 10
- Colorectal Cancer Treatments and Studies 5
- HER2/EGFR in Cancer Research 3
- Cancer Treatment and Pharmacology 2
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Amarnath Sharma (3 shared papers)Jesús Gómez-Navarro (3 shared papers)Antoni Ribas (3 shared papers)John A. Glaspy (1 shared paper)Begoña Comı́n-Anduix (1 shared paper)Elisabeth Seja (1 shared paper)Luis H. Camacho (2 shared papers)Charla A. Parker (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Clinical Cancer Research (4 papers)Molecular Cancer Therapeutics (2 papers)Pharmaceutical Research (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- United StatesItalySpain
In The Last Decade
Robert Millham
20 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Immunology 658
- Oncology 797
- Pulmonary and Respiratory Medicine 330
- Molecular Biology 638
- Genetics 94
Countries citing papers authored by Robert Millham
This map shows the geographic impact of Robert Millham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Millham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Millham more than expected).
Fields of papers citing papers by Robert Millham
This network shows the impact of papers produced by Robert Millham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Millham. The network helps show where Robert Millham may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Millham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement Hit paper breakdown → | 2006 | 504 |
| 2 | 2005 | 439 | |
| 3 | 2011 | 149 | |
| 4 | 2007 | 136 | |
| 5 | 2015 | 97 | |
| 6 | 2014 | 66 | |
| 7 | 2007 | 56 | |
| 8 | 2008 | 53 | |
| 9 | 2010 | 35 | |
| 10 | 2016 | 29 | |
| 11 | 2010 | 20 | |
| 12 | 2011 | 13 | |
| 13 | 2012 | 10 | |
| 14 | 2010 | 5 | |
| 15 | 2012 | 5 | |
| 16 | 2011 | 4 | |
| 17 | 2010 | 3 | |
| 18 | 2012 | 3 | |
| 19 | 2010 | 3 | |
| 20 | 2006 | 3 |
About Robert Millham
Robert Millham is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Immunology and Genetics, having authored 20 papers that have together received 1.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Immunotherapy and Immune Responses (3 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Immunology (658 citations), Oncology (797 citations), Pulmonary and Respiratory Medicine (330 citations), Molecular Biology (638 citations) and Genetics (94 citations). Robert Millham has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Amarnath Sharma, Jesús Gómez-Navarro, Antoni Ribas, John A. Glaspy, Begoña Comı́n-Anduix, Elisabeth Seja, Luis H. Camacho, Charla A. Parker, Gabriel Lopez‐Berestein and Dmitri Pavlov. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Molecular Cancer Therapeutics, Pharmaceutical Research and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.